Evidence map›Paper›PMID 41319044›Full record

ArticleBriefings in bioinformatics2025

Improving the predictive performance of binding affinities and poses for protein-cyclic peptide complexes through fine-tuned MM/PBSA(GBSA)-based methods.

Huifeng Zhao, Jianxiang Huang, Gaoqi Weng, Dejun Jiang, Renling Hu, Yu Kang, Tingjun Hou

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Mutational insights andFrontiers in bioinformatics · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Huifeng ZhaoCollege of Pharmaceutical Sciences, Zhejiang University, Yuhangtang Road 866, Hangzhou, Zhejiang 310058, China.
Jianxiang HuangCollege of Pharmaceutical Sciences, Zhejiang University, Yuhangtang Road 866, Hangzhou, Zhejiang 310058, China.
Gaoqi WengCollege of Pharmaceutical Sciences, Zhejiang University, Yuhangtang Road 866, Hangzhou, Zhejiang 310058, China.ORCID 0000-0001-8476-7548
Dejun JiangXiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan 410004, China.
Renling HuCollege of Pharmaceutical Sciences, Zhejiang University, Yuhangtang Road 866, Hangzhou, Zhejiang 310058, China.
Yu KangCollege of Pharmaceutical Sciences, Zhejiang University, Yuhangtang Road 866, Hangzhou, Zhejiang 310058, China.ORCID 0000-0002-0999-8802
Tingjun HouCollege of Pharmaceutical Sciences, Zhejiang University, Yuhangtang Road 866, Hangzhou, Zhejiang 310058, China.ORCID 0000-0001-7227-2580

Funding

Fundamental Research Funds for the Central Universities 2025BSSXM20Fundamental Research Funds for the Central Universities 226-2022-00220National Natural Science Foundation of China 22220102001National Natural Science Foundation of China 82204210National Natural Science Foundation of China 82204279'Pioneer' and 'Leading Goose' R&D Program of Zhejiang 2025C01117
6 · The paper itself

Abstract

Cyclic peptides represent a highly promising class of biopharmaceutical scaffolds. The screening of cyclic peptides against protein targets can be greatly facilitated using computational approaches, especially molecular docking. However, it remains a crucial challenge to accurately predict protein-cyclic peptide (P-cp) interactions employing scoring functions of molecular docking. End-point approaches, such as molecular mechanics generalized Born surface area (MM/GBSA) and molecular mechanics Poisson-Boltzmann surface area (MM/PBSA), provide theoretically more robust frameworks than conventional scoring functions, but their reliability in predicting binding affinities and discriminating native-like binding poses for P-cp complexes remains poorly quantified. Herein, we comprehensively assessed the predictive abilities of MM/PBSA(GBSA) in scoring binding affinities of P-cp complexes and re-ranking their binding poses. The binding affinity scoring ability of MM/PBSA(GBSA) was assessed on a carefully curated dataset consisting of 50 complexes involving P-cp binding affinities, and their re-ranking capability was evaluated on another dataset consisting of the decoys of 81 P-cp complexes. Based on these assessments, we proposed a two-step workflow for predicting P-cp binding affinities. First, we employed the assessed optimal re-ranking method to select the top-1 binding pose; second, we estimated the binding affinity based on the selected top-1 pose using the assessed optimal scoring method. Our proposed workflow, which requires only 3 s for each prediction, achieves binding affinity predictions with a Rp of -0.732 when compared to experimental values, which is twice as high as that of AutoDock CrankPep (Rp = -0.316). This study emphasizes the necessity of using fine-tuned MM/PBSA(GBSA) methods for predicting P-cp interactions.

Indexed as

Molecular Docking SimulationPeptides, CyclicProteinsBinding SitesProtein BindingPeptides, CyclicProteinsbinding affinityMM/PBSA(GBSA)molecular dockingprotein–cyclic peptide interactionscoring function

Identifiers

PMID41319044
PMCPMC12665037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.